ESH Video

9th Translational Research Conference: Myelodysplastic Syndromes

9th Translational Research Conference: Myelodysplastic Syndromes
April 12 - April 14, 2024 - Budapest, Hungary - #ESHMDS2024
Chairs : Pierre Fenaux, Katharina Götze, Mikkael Sekeres

Information

9th Translational Research Conference:
Myelodysplastic Syndromes

April 12-14, 2024 – Budapest, Hungary

Chairs: Pierre Fenaux, Katharina Götze, Mikkael Sekeres

#ESHMDS2024

REGISTRATION IS OPEN!

 

ABOUT THE CONFERENCE:
ESH 9th TRANSLATIONAL RESEARCH CONFERENCE ON MYELODYSPLASTIC SYNDROMES proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field.
It is open to an international audience of biologists and clinicians, including those still in-training. This translational research conference will bring together biologists and clinicians with an interest in Myelodysplastic Syndromes (MDS) in order to explore the most recent advances in the understanding of the pathogenesis and clinical behavior of the disease.

New data will be presented on how to best apply these insights to the future of MDS therapy. Diagnostic, prognostic and therapeutic issues will be presented by the faculty and ample time will be devoted to discussion with delegates.

 

“The 9th Translational Research Conference on Myelodysplastic Syndromes is that rare meeting in which the most exciting advances in basic, translational, and clinical research are discussed, debated, and celebrated as we plan for the next decade of scientific discoveries.”
– Mikkael Sekeres, Conference co-chair

 

*

 

This educational conference has been approved for 17 CME-CPD credit points by the European Board for Accreditation in Haematology (EBAH)!

Click HERE to book your accommodation at a preferential rate.

 

LEARNING OBJECTIVES:
Upon completion of this CME activity, participants should be able to:
– Learn how to optimally diagnose MDS, mainly by morphological analysis and cytogenetics, but also through the use of new tools, mainly molecular analysis.
– Improve ability to analyse prognostic factors, including new ones (revised IPSS, molecular analysis).
– Review current treatment of MDS, in both the high risk and low risk settings, ranging from single follow up to allogeneic stem cell transplantation.
– Acquire improved knowledge of emerging treatments, based on targeted therapies and well conducted clinical trials.

 

SCIENTIFIC TOPICS:
– The sinister origins of MDS
– The interplay between MDS, inflammatory, and immune abnormalities
– What’s in a name? Classifying MDS
– New tools to explore MDS
– Special populations
– Treatment of lower-risk MDS
– Treatment of higher-risk MDS
– Transplantation
– Clinical trials in MDS/CMML: cooperative groups

 

THE PROGRAMME WILL INCLUDE:
– Plenary Sessions
– Panel Discussions
– Roundtables
– Simultaneous Meet the Expert Sessions
– Poster Walks
– Brief Oral Communications

 

 

 

Programme

CLICK HERE to access the scientific programme!

Abstract submission

SUBMISSION OF ABSTRACTS FOR BRIEF ORAL COMMUNICATIONS OR POSTER PRESENTATIONS ARE CLOSED!

 

Abstracts guidelines:

– Your abstract has to be structured (eg Objectives, Methods, Results, Conclusions)

– Maximum number of words: 500

– Your abstract will be submitted to the peer review procedure.

The following file types may be uploaded: HTML document (*.htm), HTML document (*.html), JPEG image (*.jpg), GIF image (*.gif), or PNG image (*.png).

 

We accept “encore” abstract.

Presentation of data at this conference will not jeopardize acceptance of the same at the following ASH congress.

Symposia

Accommodation

Click HERE to book your accommodation at a preferential rate.

Venue

Budapest Marriott Hotel

Apaczai Csere Janos u. 4., Budapest, Hungary, 1052

Corporate partners

With the support of*:

Diamond Conference Partner
*******

Ruby Conference Partners
*******

 

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.

Scholarships

Workshop

Educational Grants

Registration

REGISTRATION IS OPEN! 

The registration fee for the ESH 9th Translational Research Conference on Myelodysplastic Syndromes is:

– 600€ for fully trained

– 300€ for in-training *

– 300€ Allied Health Professionals

– 600€ for Corporate

*A proof will be requested to confirm your status.

 

ESH is pleased to offer BSH, DGHO and PTHiT Members a 20% discount on the conference registration fees.

 

This fee includes:

Your seat in the Conference Room

The conference materials,

Welcome cocktail, luncheons, refreshments throughout the conference.

Your seat in the conference will be definitively reserved upon receipt of your fee.

 

Cancellation policy of registration fee:
In case of cancellation, up until two months prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges). If the cancellation is notified between 60 to 15 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges). Cancellations notified 15 days before the meeting will not be reimbursed. For credit card payments please register on-line first. Please note that ESH can accept VISA and MASTERCARD/EUROCARD.

Register Here